Risk of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patient Treated With Natalizumab: A Systematic Review

Natalizumab, a monoclonal antibody acting on alpha4 integrin receptors, is frequently used to treat multiple sclerosis patients. The biggest downside is the risk of development of progressive multifocal leukoencephalopathy, an immune-related condition affecting mainly the central nervous system. The...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cureus
Main Authors: Vivekanandan, Govinathan, Abubacker, Ansha P, Myneni, Revathi, Chawla, Harsh V, Iqbal, Aimen, Grewal, Amit, Ndakotsu, Andrew, Khan, Safeera
Formato: Artigo
Idioma:Inglês
Publicado em: Cureus 2021
Assuntos:
Internal Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8169000/
https://ncbi.nlm.nih.gov/pubmed/34094729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.14764
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados